Dihexa (N-Hexanoic-Tyr-Ile-(6) Aminohexanoic Amide)
The HGF-pathway small molecule at the frontier of synaptogenesis research.
Drag the vial to rotate the label
This compound is not currently available for purchase. Submit a request to help guide future inventory and testing priorities.
The HGF-pathway small molecule at the frontier of synaptogenesis research.
Dihexa is a small angiotensin IV analog engineered for oral stability that acts as an allosteric potentiator of hepatocyte growth factor (HGF) at its c-Met receptor. It is used in cultured hippocampal and cortical neurons to study spinogenesis and synaptic density, and in cell lines expressing c-Met for receptor-activation and MAPK / PI3K downstream signaling assays. Presented as a lyophilized powder for reconstitution. Research use only.
- HGF / c-Met pathway assays
- Synaptogenesis in cultured neurons
- Independently verified for identity and purity on a batch-specific basis.
- Certificates of analysis publicly accessible by lot ID — never averaged.
- Sourced through qualified manufacturing partners and shipped from the United States.
- Fast shipping, always tracked, shipped from the United States.
Research and documentation
Where this lot is in the release process
- 01
Backorder confirmed
Your product is reserved from the incoming lot.
- 02
Arriving for testing · ~6 days
Incoming lot is expected to reach our testing queue within 6 days.
- 03
Sample en route to lab
A representative sample is being sent for independent analytical testing.
- 04
Independent testing · 3–5 days
Identity, purity, and applicable analytical testing are completed.
- 05
Results verified
Results are reviewed and the certificate of analysis is published.
- 06
Ready to ship
Verified inventory is released and your order is prepared for shipment.
Timeframes are estimates. No certificate from another lot is substituted while testing is in progress.
